Revna Biosciences is honored to announce that we’ve been recognized on Bloomberg’s inaugural “Africa Startups to Watch 2025” list—a testament to our commitment to innovation across Africa. Bloomberg’s debut list shines a spotlight on African startups that are crafting inventive…
AstraZeneca, a global biopharmaceutical company is in collaboration with Revna Biosciences, a precision medicine research and advanced diagnostics company to provide EGFR (Epidermal Growth Factor Receptor) biomarker testing in Ghana. This partnership goes beyond diagnostics and research, extending towards…
The FDA approval secures RevnaBio as the first biomedical company to register/deploy the NeuMoDx platform in Sub-Saharan Africa, hitherto mainly available in Europe, the Middle East, and North America Ghana-based precision medicine company Revna Biosciences (RevnaBio) () has received historic…
Revna Biosciences, a new precision medicine company, has unveiled a purpose-built, multifunctional biomedical research facility in Accra, Ghana. Infectious disease Revna’s goal is to increase access to advanced molecular diagnostics as a first step to making precision medicine a reality…